Navigate the critical balance of M&A, affordability, and alternative funding pathways shaping our global healthcare’s future Imagine a global chess match,...
Discover the human capital’s role, the strategic interventions sequence, and the right partnership’s importance in achieving digital success in life sciences Imagine...
Why M&A strategy focusing on selling low-margin business inhibits innovation, lowers entry barriers, dilutes expertise, and weakens patient ties In the last...
It is time for cheaper, faster, more granular, and more precise clinical trials Discovering new drugs, repurposing or repositioning existing ones, and...